(2-Methyl-3-furyl)methanol; 97%; 5g; F.W.: 112.13; C6H8O2; B.P.: 76-78 (11mmHg); Primary CAS: 5554-99-4
-
P/N:
CD10514DE
- UOM: EA
- UOM Qty: 1
|
|
N-Methyl-(5-bromopyrid-3-yl)methylamine; 95%; 1g; F.W.: 201.07; C7H9BrN2; B.P.: 125 (0.2mmHg); Primary CAS: 73335-64-5
-
P/N:
CC67146DA
- UOM: EA
- UOM Qty: 1
|
|
N-Methyl-(5-bromopyrid-3-yl)methylamine; 95%; 250mg; F.W.: 201.07; C7H9BrN2; B.P.: 125 (0.2mmHg); Primary CAS: 73335-64-5
-
P/N:
CC67146CB
- UOM: EA
- UOM Qty: 1
|
|
5-bromopyridine-3-sulfonyl chloride; 97%; 1g; F.W.: 256.50; C5H3BrClNO2S; M.P.: 60-62.5; Primary CAS: 65001-21-0
-
P/N:
CC67103DA
- UOM: EA
- UOM Qty: 1
|
|
5-bromopyridine-3-sulfonyl chloride; 97%; 250mg; F.W.: 256.50; C5H3BrClNO2S; M.P.: 60-62.5; Primary CAS: 65001-21-0
-
P/N:
CC67103CB
- UOM: EA
- UOM Qty: 1
|
|
1-(thien-2-ylmethyl)piperidine-4-carboxylic acid hydrochloride hydrate; 97%; 1g; F.W.: 261.76; C11H15NO2S.ClH; M.P.: 139-155; Primary CAS: 944450-84-4
-
P/N:
CC66751DA
- UOM: EA
- UOM Qty: 1
|
|
1-(thien-2-ylmethyl)piperidine-4-carboxylic acid hydrochloride hydrate; 97%; 250mg; F.W.: 261.76; C11H15NO2S.ClH; M.P.: 139-155; Primary CAS: 944450-84-4
-
P/N:
CC66751CB
- UOM: EA
- UOM Qty: 1
|
|
[1-(thien-2-ylmethyl)piperid-4-yl]methanol; 97%; 1g; F.W.: 211.32; C11H17NOS; Primary CAS: 926921-81-5
-
P/N:
CC66709DA
- UOM: EA
- UOM Qty: 1
|
|
[1-(thien-2-ylmethyl)piperid-4-yl]methanol; 97%; 250mg; F.W.: 211.32; C11H17NOS; Primary CAS: 926921-81-5
-
P/N:
CC66709CB
- UOM: EA
- UOM Qty: 1
|
|
2-Thien-2-ylpyrimidine-5-carboxylic acid; 97%; 1g; F.W.: 206.21; C9H6N2O2S; M.P.: 291-295.5; Primary CAS: 916766-97-7
-
P/N:
CC66501DA
- UOM: EA
- UOM Qty: 1
|
|
